Prescription pattern audit plan in Maharashtra evokes mixed reactions
EVEN as four agencies have applied for the contract for the ambitious plan of Maharashtra government to generate information regarding misuse and irrational prescription of drugs in government hospitals across the state, the plan itself has evoked mixed reactions from the pharma industry and healthcare professionals.

IP lists 19 HIV drug monographs
The Indian Pharmacopoeia, through its 2002 addendum, has published monographs of 12 anti-retroviral bulk drugs and seven anti-retroviral formulations for the first time

Crude, unstable intermediates will not attract excise duty: SC
The Supreme Court has quashed the show cause notice issued by Customs, Excise and Gold Control Appellate Tribunal (CEGAT) demanding excise duties on intermediary products obtained while manufacturing of drugs.

IDMA, OPPI assure AIOCD of sympathetic consideration on losses due to VAT
The Indian Drug Manufacturers’ Association (IDMA), the Organisation of Pharmaceutical Producers of India have assured the All India Organisation of Chemists and Druggists (AIOCD) that they will sympathetically consider the losses incurred by the wholesalers on account of implementation of VAT.